Skip to main content

Table 1 Patient characteristics

From: Serotype-specific mortality from invasive Streptococcus pneumoniaedisease revisited

  Mortality rate, % Survivors No. (%) Non-survivors No. (%) P value
Age, years     
18–49 17.8 83 (25.9) 18 (14.6)  
50–65 33.8 47 (14.5) 24 (19.6)  
65–79 29.6 114 (35.5) 48 (39.0)  
> 80 30.0 77 (24.0) 33 (26.8) 0.077
Sex     
Female 29.4 199 (58.4) 64 (52.0)  
Male 24.3 142 (41.6) 59 (48.0) 0.244
Focus     
Bacteremia 35.4 62 (20.5) 34 (27.6)  
Pneumonia 27.1 226 (74.8) 84 (68.3)  
Meningitis 44.4 5 (1.7) 4 (0.8)  
Otitis media 10.0 9 (3.0) 1 (3.3) 0.153
Comorbidity*     
No 23.6 133 (43.8) 41 (33.3)  
Yes 32.4 171 (56.2) 82 (66.7) 0.047
Alcoholism     
No 27.0 265 (87.2) 98 (79.7)  
Yes 39.1 39 (12.8) 25 (20.3) 0.049
Smoking status     
Never 27.1 70 (29.8) 26 (33.3)  
Current or former 24.0 165 (70.2) 52 (66.7) 0.573
Splenectomy     
No 28.6 300 (98.7) 120 (97.6)  
Yes 42.9 4 (1.3) 3 (2.4) 0.416
Intravenous drug use     
No 29.4 293 (96.4) 122 (99.2)  
Yes 8.3 11 (3.6) 1 (0.8) 0.193
Nursing home residence     
Yes 27.6 21 (7.7) 8 (7.1)  
No 27.2 279 (92.3) 104 (92.9) 0.984
Temperature     
≥ 38.5°C 22.8 210 (71.9) 62 (56.4)  
< 38.5°C 36.9 82 (28.1) 48 (43.6) 0.003
B-leukocytes     
> 9 10 9 /L 24.7 216 (81.8) 71 (65.7)  
≤ 9 10 9 /L 43.5 48 (18.2) 37 (34.3) 0.001
  1. *: includes patients with chronic lung disease, chronic heart disease, chronic renal disease, chronic liver disease, diabetes mellitus, cancer, autoimmune disease, human immunodeficiency virus (HIV) infection, and 'other chronic diseases'. Patients may have more than one comorbidity.